$10.55 Million in Sales Expected for Theravance Biopharma Inc (TBPH) This Quarter
Equities research analysts expect that Theravance Biopharma Inc will post $10.55 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Theravance Biopharma's earnings, with the highest sales estimate coming in at $12.50 million and the lowest estimate coming in at $8.64 million.
Start the conversation, or Read more at AmericanBankingNews.com.
Copyright © 2018 Topix LLC